CareDx (CDNA)
(Delayed Data from NSDQ)
$12.22 USD
-0.07 (-0.53%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDNA 12.22 -0.07(-0.53%)
Will CDNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDNA
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
CareDx (CDNA) Tops Q1 Earnings Estimates
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?
Here's Why Community Health's Florida Divestiture Matters
New Strong Buy Stocks for February 27th
Other News for CDNA
CareDx price target lowered by $4 at BTIG, here's why
BTIG Adjusts Price Target for CareDx (CDNA) Ahead of Q2 Earnings
CareDx to Report Second Quarter 2025 Financial Results | CDNA Stock News
CareDx Inc (CDNA) Trading 7.85% Higher on Jul 21
CareDx (CDNA): Analyst Rating Maintained, Price Target Lowered | CDNA Stock News